Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations

References

• Davis SS, Washington C, West P, et al. Lipid emulsions as drug delivery systems. Ann N Y Acad Sci 1987;507:75–88
   PubMed Web of Science ®Google Scholar
• Collins-Gold LC, Lyons RT, Bartholow LC. Parenteral emulsions for drug delivery. Adv Drug Deliv Rev 1990;5:189–208
   Google Scholar
• Washington C. Stability of lipid emulsions for drug delivery. Adv Drug Deliv Rev 1996;20:131–45
   Web of Science ®Google Scholar
• Prankerd RJ, Stella VJ. The use of oil-in-water emulsions as a vehicle for parenteral drug administration. J Parenter Sci Technol 1990;44:139–49
   PubMedGoogle Scholar
• Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297–305
   PubMedGoogle Scholar
• Couvreur P, Dubernet C, Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm 1995;41:2–13
   Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Sussman E, Clark M, Shastri VP. Functionalized polymeric nanoparticles. MRS Proceedings. Cambridge, UK: Cambridge University Press; 2004:M12–19
   Google Scholar
• Smith A. Evaluation of poly (lactic acid) as a biodegradable drug delivery system for parenteral administration. Int J Pharm 1986;30:215–20
   Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 2007;340:153–62
   PubMed Web of Science ®Google Scholar
• Yatvin MB, Parks DW, McClard RW, et al. Covalent lipid-drug conjugates for drug targeting. U.S. Patent No. 5,149,794. 22 September 1992
   Google Scholar
• Fundarò A, Cavalli R, Bargoni A, et al. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol Res 2000;42:337–43
   PubMed Web of Science ®Google Scholar
• Gasco M, Antonelli PL. Method for producing solid lipid microspheres having a narrow size distribution. Maria R. Gasco, Torino, Italy; US 5250236 A;1993:1–4
   Google Scholar
• Zur Mühlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanism. Eur J Pharm Biopharm 1998;45:149–55
   PubMed Web of Science ®Google Scholar
• Müller RH, Lucks JS. Arzneistoffträger aus festen Lipidteilchen – Feste Lipid Nanosphären (SLN). Germanny; 0605497; 1996
   Google Scholar
• Takagi T. Electrophoretic light scattering. Electrophoresis 1993;14:1255–6
   Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–77
   PubMed Web of Science ®Google Scholar
• Yang SC, Lu LF, Cai Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release 1999;59:299–307
   PubMed Web of Science ®Google Scholar
• Abuasal B, Lucas C, Peyton B, et al. Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability. Lipids 2012;47:461–9
   PubMed Web of Science ®Google Scholar
• Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004;56:1527–35
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Shaw J, Al-Kassas R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv 2010;17:467–89
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting H-C. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007;59:427–43
   PubMed Web of Science ®Google Scholar
• Same T, Müller RH, Mehnert W, et al. Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1995;41:62–9
   Web of Science ®Google Scholar
• Schwarz C, Mehnert W, Lucks JS, Miiller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release 1994;30:83–96
   Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–96
   PubMed Web of Science ®Google Scholar
• Bunjes H. Lipid nanoparticles for the delivery of poorly water-soluble drugs. J Pharm Pharmacol 2010;62:1637–45
   PubMed Web of Science ®Google Scholar
• Hu H, Liu D, Zhao X, et al. Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. Drug Dev Ind Pharm 2013;39:770–9
   PubMed Web of Science ®Google Scholar
• Yucel U, Elias RJ, Coupland JN. 6 Emulsions, nanoemulsions and solid lipid nanoparticles as delivery systems in foods. Food Ind Bioprod Bioprocess 2012;167:146–54
   Google Scholar
• Montana G, Bondì ML, Carrotta R, et al. Employment of cationic solid-lipid nanoparticles as RNA carriers. Bioconjug Chem 2007;18:302–8
   PubMed Web of Science ®Google Scholar
• Delgado D, Gascón AR, Del Pozo-Rodríguez A, et al. Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice. Int J Pharm 2012;425:35–43
   PubMed Web of Science ®Google Scholar
• Ma B, Zhang S, Jiang H, et al. Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J Control Release 2007;123:184–94
   PubMed Web of Science ®Google Scholar
• Del Pozo-Rodríguez A, Pujals S, Delgado D, et al. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors. J Control Release 2009;133:52–9
   PubMed Web of Science ®Google Scholar
• Yang R, Gao R, Li F, et al. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. Drug Dev Ind Pharm 2011;37:139–48
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping Q, Huang G, et al. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 2006;327:153–9
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Runge S, Müller RH. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm 1997;149:255–65
   Web of Science ®Google Scholar
• Li P, Nielsen HM, Müllertz A. Oral delivery of peptides and proteins using lipid-based drug delivery systems. Exp Opinion Drug Deliv 2012;9:1289–304
   PubMed Web of Science ®Google Scholar
• Martins S, Tho I, Ferreira DC, et al. Physicochemical properties of lipid nanoparticles: effect of lipid and surfactant composition. Drug Dev Ind Pharm 2011;37:815–24
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev 2007;59:411–18
   PubMed Web of Science ®Google Scholar
• Schie IW, Nolte L, Pedersen TL, et al. Direct comparison of fatty acid ratios in single cellular lipid droplets as determined by comparative Raman spectroscopy and gas chromatography. Analyst 2013;138:6662–70
   PubMed Web of Science ®Google Scholar
• Arnold YE, Imanidis G, Kuentz M. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life. Drug Dev Ind Pharm 2012;38:1262–9
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang X, Wu H, et al. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 2011;37:475–81
   PubMed Web of Science ®Google Scholar
• Hu H, Liu D, Zhao X, et al. Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. Drug Dev Ind Pharm 2013;39:770–9
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Kanaujia P, et al. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Colloids Surf B Biointerfaces 2011;88:483–9
   PubMed Web of Science ®Google Scholar
• Özbek B, Ülgen KÖ. The stability of enzymes after sonication. Process Biochem 2000;35:1037–43
   Web of Science ®Google Scholar
• Olbrich C, Gessner A, Kayser O, Müller RH. Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate. J Drug Target 2002;10:387–96
   PubMed Web of Science ®Google Scholar
• Olbrich C, Gessner A, Schröder W, et al. Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption. J Control Release 2004;96:425–35
   PubMed Web of Science ®Google Scholar
• Vadlapudi AD, Vadlapatla RK, Kwatra D, et al. Targeted lipid based drug conjugates: a novel strategy for drug delivery. Int J Pharm 2012;434:315–24
   PubMed Web of Science ®Google Scholar
• Neupane YR, Sabir MD, Ahmad N, et al. Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies. Nanotechnology 2013;24:415102. doi: 10.1088/0957-4484/24/41/415102
   PubMed Web of Science ®Google Scholar
• Kovacevic A, Savic S, Vuleta G, et al. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm 2011;406:163–72
   PubMed Web of Science ®Google Scholar
• Li P, Ghosh A, Wagner RF, et al. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 2005;288:27–34
   PubMed Web of Science ®Google Scholar
• McClements DJ. Edible lipid nanoparticles: digestion, absorption, and potential toxicity. Prog Lipid Res 2013;52:409–23
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257–72
   PubMed Web of Science ®Google Scholar
• Wei C-C, Ge Z-Q. Influence of electrolyte and poloxamer 188 on the aggregation kinetics of solid lipid nanoparticles (SLNs). Drug Dev Ind Pharm 2012;38:1084–9
   PubMed Web of Science ®Google Scholar
• Guo X, Xing Y, Mei Q, et al. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles. Anticancer Drugs 2012;23:185–90
   PubMed Web of Science ®Google Scholar
• Jenning V, Lippacher A, Gohla SH. Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization. J Microencapsul 2002;19:1–10
   Google Scholar
• Müller RH, Dingler A, Schneppe T, Gohla S. Large-scale production of solid lipid nanoparticles (SLN) and nanosuspensions (DissoCubes). In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000:359–76
   Google Scholar
• Morel S, Rosa Gasco M, Cavalli R. Incorporation in lipospheres of [D-Trp-6] LHRH. Int J Pharm 1994;105:R1–3
   Web of Science ®Google Scholar
• Xie S, Zhu L, Dong Z, et al. Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids. Colloids Surfaces B Biointerfaces 2011;83:382–7
   PubMed Web of Science ®Google Scholar
• Lopes R, Eleutério C V, Gonçalves LMD, et al. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. Eur J Pharm Sci 2012;45:442–50
   PubMed Web of Science ®Google Scholar
• Hippalgaonkar K, Adelli GR, Hippalgaonkar K, et al. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther 2013;29:216–28
   Google Scholar
• Kuntsche J, Bunjes H. Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles. Eur J Pharm Biopharm 2007;67:612–20
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Al-Kassas R. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev Ind Pharm 2013;39:508–19
   PubMed Web of Science ®Google Scholar
• Joshi AS, Patel HS, Belgamwar VS, et al. Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation. J Mater Sci Mater Med 2012;23:2163–75
   PubMed Web of Science ®Google Scholar
• Westesen K, Siekmann B, Koch MHJ. Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int J Pharm 1993;93:189–99
   Web of Science ®Google Scholar
• Cavalli R, Aquilano D, Carlotti ME, Gasco MR. Study by X-ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles. Eur J Pharm Biopharm 1995;41:329–33
   Web of Science ®Google Scholar
• Siekmann B, Westesen K. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surfaces B Biointerfaces 1994;3:159–75
   Google Scholar
• Bunjes H, Westesen K, Koch MHJ, Michel HJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996;129:159–73
   Web of Science ®Google Scholar
• Jenning V, Thünemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000;199:167–77
   PubMed Web of Science ®Google Scholar
• Manolova V, Flace A, Bauer M, et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008;38:1404–13
   PubMed Web of Science ®Google Scholar
• Tscharnuter W. Photon correlation spectroscopy in particle sizing. Encyclopedia of Analytical Chemistry NY, USA: John Wiley & Sons, Ltd; 2006
   Google Scholar
• Berne B, Pecora R. Dynamic light scattering: with applications to chemistry, biology, and physics. Biology and Physics. New York: Wiley; 1976
   Google Scholar
• Hu F-Q, Zhang Y, Du Y-Z, Yuan H. Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. Int J Pharm 2008;348:146–52
   PubMed Web of Science ®Google Scholar
• Yu WL, Borkovec M. Distinguishing heteroaggregation from homoaggregation in mixed binary particle suspensions by multiangle static and dynamic light scattering. J Phys Chem B 2002;106:13106–10
   Web of Science ®Google Scholar
• Vivek K, Reddy H, Murthy RSR. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 2007;8:E83. doi: 10.1208/pt0804083
   PubMed Web of Science ®Google Scholar
• Pardeike J, Weber S, Matsko N, Zimmer A. Formation of a physical stable delivery system by simply autoclaving nanostructured lipid carriers (NLC). Int J Pharm 2012;439:22–7
   PubMedGoogle Scholar
• Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008;69:1–9
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Drechsler M, et al. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release 2004;95:217–27
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002;249:127–38
   PubMed Web of Science ®Google Scholar
• Shekunov BY, Chattopadhyay P, Tong HHY, Chow AHL. Particle size analysis in pharmaceutics: principles, methods and applications. Pharm Res 2007;24:203–27
   PubMed Web of Science ®Google Scholar
• Yang L, Broom MF, Tucker IG. Characterization of a nanoparticulate drug delivery system using scanning ion occlusion sensing. Pharm Res 2012;29:2578–86
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLNTM) dispersions. Int J Pharm 1998;168:221–9
   Web of Science ®Google Scholar
• Vogel R, Willmott G, Kozak D, et al. Quantitative sizing of nano/microparticles with a tunable elastomeric pore sensor. Anal Chem 2011;83:3499–506
   PubMed Web of Science ®Google Scholar
• Freitas C, Müller R. Stability determination of solid lipid nanoparticles (SLN TM) in aqueous dispersion after addition of electrolyte. J Microencapsul 1999;16:59–71
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Müller RH. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLNTM) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 2001;52:203–10
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010;9:615–27
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Bunjes H, Drechsler M. From solid lipid nanoparticles (SLN) to nanospoons. Visions and reality of colloidal lipid dispersions. 30th International Symposium on Controlled Release of Bioactive material; 2003:1–2; Glasglow, UK
   Google Scholar
• Patel MR, San Martin-Gonzalez MF. Characterization of ergocalciferol loaded solid lipid nanoparticles. J Food Sci 2012;77:N8–13
   PubMed Web of Science ®Google Scholar
• Yin Win K, Feng S-S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26:2713–22
   PubMed Web of Science ®Google Scholar
• Kumar S, Randhawa JK. High melting lipid based approach for drug delivery: solid lipid nanoparticles. Mater Sci Eng C Mater Biol Appl 2013;33:1842–52
   PubMed Web of Science ®Google Scholar
• McCaffrey JP, Phaneuf MW, Madsen LD. Surface damage formation during ion-beam thinning of samples for transmission electron microscopy. Ultramicroscopy 2001;87:97–104
   PubMed Web of Science ®Google Scholar
• Thach RE, Thach SS. Damage to biological samples caused by the electron beam during electron microscopy. Biophys J 1971;11:204–10
   PubMed Web of Science ®Google Scholar
• Steinbrecht RA, Zierold K. Cryotechniques in biological electron microscopy. New York: Springer Verlag; 1987
   Google Scholar
• Garti N, Sato K. Crystallization and polymorphism of fats and fatty acids New York and Basel: Acids Marcel Dekker; 1998
   Google Scholar
• Dubes A, Parrot-Lopez H, Abdelwahed W, et al. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm 2003;55:279–82
   PubMed Web of Science ®Google Scholar
• Erlandsen SLOF, Chris C, Chen Y. Cryo field emission scanning electron microscopy. BioTechniques 2001;31:300–5
   PubMed Web of Science ®Google Scholar
• Binnig G, Quate CF, Gerber C. Atomic force microscope. Phys Rev Lett 1986;56:930–3
   PubMed Web of Science ®Google Scholar
• Yalamanchili MR,Veeramasuneni S, Azevedo MAD, Miller JD. Use of atomic force microscopy in particle science and technology research. Colloids Surf B Biointerfaces 1998;133:77–188
   Web of Science ®Google Scholar
• O’Brien RWW, Cannon DWW, Rowlands WNN. Electroacoustic determination of particle size and zeta potential. J Colloid Interface Sci 1995;173:406–18
   Web of Science ®Google Scholar
• Ware BR, Haas DD. Electrophoretic light scattering. In: Sha’afi RI, Fernandez SM, eds. Fast methods in physical biochemistry and cell biology. New York: Elsevier; 1983:173–220
   Google Scholar
• Xu R. Progress in nanoparticles characterization: sizing and zeta potential measurement. Particuology 2008;6:112–15
   Web of Science ®Google Scholar
• Fujimoto T, Morisawa K, Sekiwa M, et al. Electrophoretic mobility measuring apparatus. Japan: USPTO; US7449097 B2; 2008
   Google Scholar
• Sarmento B, Mazzaglia D, Bonferoni MC, et al. Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system. Carbohydr Polym 2011;84:919–25
   Web of Science ®Google Scholar
• Qi L, Xu Z, Jiang X, et al. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg Med Chem Lett 2005;15:1397–9
   PubMed Web of Science ®Google Scholar
• Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 2006;5:1909–17
   PubMed Web of Science ®Google Scholar
• Harris RK. Polymorphism in the pharmaceutical industry. Angew Chemie Int Ed 2006;45:6609. doi: 10.1002/anie.200685424
   Google Scholar
• Chapman D. The polymorphism of glycerides. Chem Rev 1962;62:433–56
   Web of Science ®Google Scholar
• Freitas C, Müller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999;47:125–32
   PubMed Web of Science ®Google Scholar
• Jenning V, Schäfer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 2000;66:115–26
   PubMed Web of Science ®Google Scholar
• Westesen K, Bunjes H. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int J Pharm 1995;115:129–31
   Web of Science ®Google Scholar
• Langevelde A, Malssen K, Peschar R, Schenk H. Effect of temperature on recrystallization behavior of cocoa butter. J Am Oil Chem Soc 2001;78:919–25
   Web of Science ®Google Scholar
• Bunjes H, Koch MHJ, Westesen K. Effect of particle size on colloidal solid triglycerides. Langmuir 2000;16:5234–41
   Web of Science ®Google Scholar
• Laura C, Milena S, Giovanna B, et al. Characterization of silver sulfadiazine-loaded solid lipid nanoparticles by thermal analysis. J Therm Anal Calorim 2012;111:2149–55
   Web of Science ®Google Scholar
• Khan M, Sultana Y, Ali A, et al. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J Drug Target 2009;18:191–204
   Web of Science ®Google Scholar
• Thiebaud S, Aburto J, Alric I, et al. Properties of fatty-acid esters of starch and their blends with LDPE. J Appl Polym Sci 1997;65:705–21
   Web of Science ®Google Scholar
• Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110:296–306
   PubMed Web of Science ®Google Scholar
• Silva A, Santos D, Ferreira D, Souto E. No Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. PHARMAZIE 2009;64:177–82
   PubMed Web of Science ®Google Scholar
• Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm 2006;314:56–62
   PubMed Web of Science ®Google Scholar
• Noack A, Hause G, Mäder K. Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. Int J Pharm 2012;423:440–51
   PubMed Web of Science ®Google Scholar
• Jenning V, Mäder K, Gohla SH. Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a (1)H-NMR study. Int J Pharm 2000;205:15–21
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen D, Ren L, et al. Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release 2006;114:53–9
   PubMed Web of Science ®Google Scholar
• Kotikalapudi LS, Adepu L, Vijayaratna J, Diwan PV. Formulation and invitro characterization of domperidone loaded solid lipid nanoparticles. Int J Pharm 2012;3:22–9
   Google Scholar
• Yang SR, Lee HJ, Kim J-D. Histidine-conjugated poly(amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin. J Control Release 2006;114:60–8
   PubMed Web of Science ®Google Scholar
• Xu X, Fu Y, Hu H, et al. Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography. J Pharm Biomed Anal 2006;41:266–73
   PubMed Web of Science ®Google Scholar
• Aji Alex MR, Chacko AJ, Jose S, Souto EB. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 2011;42:11–18
   PubMed Web of Science ®Google Scholar
• Başaran E, Demirel M, Sirmagül B, Yazan Y. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 2010;27:37–47
   PubMed Web of Science ®Google Scholar
• Qi C, Chen Y, Huang J-H, et al. Preparation and characterization of catalase-loaded solid lipid nanoparticles based on soybean phosphatidylcholine. J Sci Food Agric 2012;92:787–93
   PubMed Web of Science ®Google Scholar
• Castro GA, Oréfice RL, Vilela JMC, et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul 2007;24:395–407
   PubMed Web of Science ®Google Scholar
• Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007;59:522–30
   PubMed Web of Science ®Google Scholar
• Lee M-K, Lim S-J, Kim C-K. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007;28:2137–46
   PubMed Web of Science ®Google Scholar
• Dong Z, Xie S, Zhu L, et al. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery. Drug Deliv 2011;18:441–50
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Fu H, et al. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008;356:333–44
   PubMed Web of Science ®Google Scholar
• Schultz SG. Determination of the effective hydrodynamic radii of small molecules by viscometry. J Gen Physiol 1961;44:1189–99
   PubMed Web of Science ®Google Scholar
• De Boer GBJ, de Weerd C, Thoenes D, Goossens HWJ. Laser diffraction spectrometry: Fraunhofer diffraction versus Mie scattering. Part Part Syst Charact 1987;4:14–19
   Web of Science ®Google Scholar
• Roberts GS, Kozak D, Anderson W, et al. Tunable nano/micropores for particle detection and discrimination: scanning ion occlusion spectroscopy. Small 2010;6:2653–8
   PubMed Web of Science ®Google Scholar
• Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm 2002;241:341–4
   PubMed Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781–5
   PubMed Web of Science ®Google Scholar
• Kaul G, Amiji M. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res 2002;19:1061–7
   PubMed Web of Science ®Google Scholar
• Léon V, Rabier J, Notonier R, et al. Effects of three nickel salts on germinating seeds of Grevillea exul var. rubiginosa, an endemic serpentine Proteaceae. Ann Bot 2005;95:609–18
   PubMed Web of Science ®Google Scholar
• Lapshin RV. Feature-oriented scanning methodology for probe microscopy and nanotechnology. Nanotechnology 2004;15:1135–51
   Web of Science ®Google Scholar
• Cavalli R, Caputo O, Eugenia M, et al. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. J Pharm 1997;148:47–54
   Google Scholar
• Lim S-J, Kim C-K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002;243:135–46
   PubMed Web of Science ®Google Scholar